No photo of Emma I Andersson

Emma I Andersson

20122023

Research activity per year

Network

Caroline Heckman, Research Director

Person: UH , U4 Research and teaching staff

Jing Tang

Person: U3 Research and teaching staff, UH

Kirsi Talala

Person: Teaching and research personnel

Pirkko Mattila

Person: U4 Research and teaching staff

Thomas P. Loughran

  • Univ Virginia, University of Virginia
  • Virginia Commonwealth Univ, Virginia Commonwealth University, Med Ctr, Dept Surg

External person

Fumihiro Ishida

  • Shinshu University
  • Shinshu Univ, Shinshu University, Sch Med, Dept Biomed Lab Sci
  • Shinshu Univ, Shinshu University, Dept Biol

External person

Nodoka Sekiguchi

  • Shinshu University
  • Shinshu Univ, Shinshu University, Sch Med, Dept Comprehens Canc Therapy

External person

Won Seog Kim

  • Sungkyunkwan Univ, Sungkyunkwan University
  • Sungkyunkwan Univ, Sungkyunkwan University, Samsung Medical Center, Samsung Med Ctr, Div Hematol & Oncol, Sch Med
  • Sungkyunkwan Univ, Sungkyunkwan University (SKKU), Samsung Medical Center, Sch Med, Samsung Med Ctr, Dept Hematol Oncol

External person

Monica Hellesøy

  • University of Bergen

External person

Junji Suzumiya

  • Shimane University
  • Shimane Univ Hosp, Shimane University, Dept Oncol Hematol

External person

Andres Jerez

  • Cleveland Clin, Cleveland Clinic Foundation, Taussig Canc Inst, Dept Translat Hematol & Oncol Res
  • Univ Murcia, University of Murcia, Hosp Univ Morales Meseguer, IMIB Arrixaca, Hematol & Med Oncol Dept
  • Univ Murcia, University of Murcia, Ctr Reg Hemodonac, Hosp Morales Meseguer, IMIB,Hematol & Med Oncol Dept

External person

Shih-Sung Chuang

  • Chi Mei Hospital
  • Chi Mei Med Ctr, Chi Mei Hospital, Dept Pathol

External person

Jaroslaw P. Maciejewski

  • Cleveland Clin, Cleveland Clinic Foundation, Taussig Canc Inst, Dept Translat Hematol & Oncol Res
  • Cleveland Clin, Cleveland Clinic Foundation, Taussig Canc Inst, Leukemia Program, Dept Hematol & Med Oncol
  • Cleveland Clin, Cleveland Clinic Foundation, Taussig Canc Inst, Dept Translat Hematol & Oncol Res
  • Cleveland Clin, Cleveland Clinic Foundation, Dept Neurol

External person

Marco Herling

  • Univ Cologne, University of Cologne, Dept Internal Med 1, CMMC, CIO ABCD,CECAD
  • Univ Leipzig, University of Leipzig

External person

Koichi Ohshima

  • Kurume Univ, Kurume University, Biostat Ctr
  • Kurume Univ, Kurume University, Sch Med, Dept Pathol

External person

Hideyuki Nakazawa

  • Shinshu Univ, Shinshu University, Sch Med, Dept Internal Med, Div Hematol
  • Shinshu Univ, Shinshu University, Dept Biol

External person

Vanessa Rebecca Gasparini

  • VIMM, Veneto Institute Molecular Medicine

External person

Ritsuro Suzuki

  • Shimane Univ Hosp, Shimane University, Dept Oncol Hematol

External person

Michael J. Clemente

  • Cleveland Clin, Cleveland Clinic Foundation, Taussig Canc Inst, Dept Translat Hematol & Oncol Res
  • Cleveland Clin, Cleveland Clinic Foundation, Taussig Canc Inst, Dept Translat Hematol & Oncol Res

External person

Despina Bazou

  • Mater Misericordiae University Hospital
  • Mater Misericordiae Univ Hosp, Mater Misericordiae University Hospital, University College Dublin, Dept Hematol
  • University College Dublin

External person

Paul Dowling

  • National University of Ireland, Maynooth
  • Maynooth University
  • Dept Biol

External person

Young Hyeh Ko

  • Sungkyunkwan Univ, Sungkyunkwan University
  • Samsung Med Ctr, Samsung, Samsung Medical Center, Sungkyunkwan University, Dept Pathol

External person

M. Herling

  • University of Cologne, Cologne Graduate School
  • Univ Cologne UoC, Ctr Mol Med, CMMC
  • UoC, University of Cologne, CMMC
  • Univ Cologne UoC, University of Cologne, Ctr Mol Med Cologne

External person

T. H. Bruemmendorf

  • Rhein Westfal TH Aachen, RWTH Aachen University, Univ Hosp Aachen, Dept Oncol Hematol & Stem Cell Transplantat
  • Rhein Westfal TH Aachen, RWTH Aachen University, Med Sch, Dept Hematol Oncol & Stem Cell Transplantat

External person

Marco Herling

  • Department I of Internal Medicine, Center for Integrated Oncology (CIO), University of Cologne (UoC), Germany
  • Univ Cologne, University of Cologne, Ctr Mol Med, CMMC
  • Univ Leipzig, Leipzig University, Dept Hematol Cellular Therapy & Hemostaseol

External person

Kerstin Putzker

  • EMBL, European Molecular Biology Laboratory (EMBL), Chem Biol Core Facil

External person

Lisa Moris

  • ESMO Guidelines Comm, European Society for Medical Oncology, ESMO Head Off
  • European Association of Urology

External person

M. Peifer

  • UoC, Dept Translat Genom

External person

Henrik Hjorth-Hansen

  • Norwegian University of Technology and Science, NTNU
  • Norwegian University of Science and Technology (NTNU)
  • Norwegian Univ Sci & Technol NTNU, Norwegian University of Science & Technology, St Olavs Hosp, Dept Hematol
  • St Olavs Hosp, Norwegian University of Science & Technology (NTNU), Dept Haematol
  • Norwegian Univ Sci & Technol NTNU, Norwegian University of Science & Technology (NTNU), Dept Clin & Mol Med IKOM
  • Norwegian Univ Sci & Technol NTNU, Norwegian University of Science & Technology, Norwegian University of Science & Technology (NTNU), St Olavs Hosp, Dept Canc Res & Mol Med

External person

Jeffrey W. Tyner

  • Univ Oregon, Oregon University System, University of Oregon
  • Oregon Hlth & Sci Univ, Oregon Health & Science University, Knight Canc Inst, Div Hematol & Med Oncol

External person

Leena Tiainen

  • Tampere University Hospital (TAYS)
  • Univ Tampere, Tampere University, Tampere University Hospital, Tampere Univ Hosp, Fac Med & Hlth Technol, Allergy Ctr
  • Univ Tampere, Tampere University, Tampere University Hospital, Tampere Univ Hosp, Fac Med & Life Sci, Dept Oncol
  • Tampere Univ, Tampere University, Tampere University Hospital, Fac Med & Life Sci, Tampere Univ Hosp, Dept Surg
  • Tampere Univ Hosp, Tampere University, Tampere University Hospital, Div Nephrol
  • Fimlab Ltd, Tampere University, Tampere University Hospital, Tampere Univ Hosp
  • Tampere University
  • Tampere University Hospital

External person

Jesus M. Lopez Marti

  • Univ Helsinki, University of Helsinki, Inst Mol Med FIMM

External person

Jack Schalken

  • Radboud University Nijmegen
  • Radboud University Medical Center

External person

E. S. Sisca

  • San Raffaele Scientific Institute

External person

Stefania Bortoluzzi

  • Univ Padua, University of Padua, CRIBI Interdept Res Ctr Innovat Biotechnol CRIBI

External person

Ana Marcos Jimenez

  • Hosp Univ La Princesa, Inst Invest Sanitaria Princesa IIS IP, Dept Immunol
  • Hosp Univ La Princesa, Hospital de La Princesa, Dept Immunol, IIS IP

External person

Kirill Shiranov

  • European Association of Urology

External person

Reidun K. Kopperud

  • University of Bergen

External person

Marco Herling

  • Univ Hosp Cologne, University of Cologne, Dept Internal Med 1
  • Univ Hosp Cologne, University of Cologne, Ctr Mol Med Cologne, Dept Obstet & Gynaecol, Div Mol Gynecooncol
  • UoC, University of Cologne, Ctr Mol Med Cologne CMMC
  • Univ Leipzig, University of Leipzig

External person

Sebastian Oberbeck

  • Univ Cologne, University of Cologne, Ctr Mol Med, CMMC

External person

N. Weit

  • Univ Cologne UoC, Ctr Mol Med, CMMC

External person

Andy Awwad

  • Penn State Coll Med, Penn State University, Pennsylvania Commonwealth System of Higher Education (PCSHE), Penn State Hershey Canc Inst

External person

L. Leardini

  • Univ Heidelberg Hosp, Ruprecht Karl University Heidelberg
  • Heidelberg University
  • San Raffaele Scientific Institute

External person

Michael J. Clemente

  • Cleveland Clin, Cleveland Clinic Foundation, Taussig Canc Inst, Dept Translat Hematol & Oncol Res

External person

A. Hijazy

  • Association EISBM

External person

Pilar Ayuda-Duran

  • Oslo University
  • Oslo University Hospital and University of Oslo
  • University of Oslo

External person

J. Maciejewski

  • Cleveland Clin Fdn, Cleveland Clinic Foundation

External person

T. Hannunen

  • University of Helsinki, Helsinki

External person

Ingo Ringshausen

  • Harvard University

External person

Susan Evans-Axelsson

  • Lund University

External person

Tait tohtori Jan Kenneth Weckman

  • Kuvataideakatemia
  • Univ Cologne UoC, Ctr Mol Med, CMMC

External person

P. Nuernberg

  • Univ Cologne, Cologne Ctr Genom
  • Univ Cologne UoC, Inst Human Genet

External person

Jussi Koivunen

  • Oulu Univ Hosp, University of Oulu, Northern Ostrobothnia Hosp Dist
  • Oulu Univ Hosp, University of Oulu, MRC Oulu, Dept Obstet & Gynecol
  • Oulu Univ Hosp, University of Oulu, MRC Med Reasearch Ctr, Dept Oncol & Radiotherapy
  • PEDEGO Research Unit, MRC Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland
  • University of Oulu

External person

Anthony D. Ho

  • Univ Heidelberg Hosp, Ruprecht Karl University Heidelberg, Dept Med

External person

Lena Wagner

  • German Canc Res Ctr, German Cancer Research Center, Helmholtz Association, Unit Mol Epidemiol C080, DKFZ

External person

Toru Kawakami

  • Shinshu Univ, Shinshu University, Sch Med, Dept Internal Med, Div Hematol
  • Shinshu Univ, Shinshu University, Dept Biol

External person

M. Gacci

  • European Association of Urology

External person

R. Moriggl

  • Med Univ Vienna, Medical University of Vienna, Ludwig Boltzmann Institute, Ludwig Boltzmann Inst Canc Res

External person

M. S. Ventura Ferreira

  • Rhein Westfal TH Aachen, RWTH Aachen University, Med Sch, Dept Hematol Oncol & Stem Cell Transplantat

External person

Marina Espartero-Santos

  • Hosp Univ La Princesa, Hospital de La Princesa, Dept Immunol, IIS IP

External person

Lorena Vega-Piris

  • Hosp Univ La Princesa, Hospital de La Princesa, Methodol Unit, IIS IP

External person

J. Joseph Melenhorst

  • NHLBI, National Institutes of Health (NIH) - USA, NIH National Heart Lung & Blood Institute (NHLBI), Stem Cell Allogene Transplantat Sect, Hematol Branch, NIH

External person

K Bayer

  • Kings College

External person

Alexandra Schrader

  • Univ Cologne, University of Cologne, Cologne Bioctr, Inst Genet
  • CNRS, Centre National de la Recherche Scientifique (CNRS), IRIF

External person

Florence Nguyen-Khac

  • Hop La Pitie Salpetriere, Pierre & Marie Curie University - Paris VI, Hopital Universitaire Pitie-Salpetriere - APHP, Assistance Publique Hopitaux Paris (APHP), Sorbonne Universite, Serv Hematol Biol

External person

Wing C. Chan

  • City Hope Med Ctr, City of Hope, Dept Pathol
  • City Hope Natl Med Ctr, City of Hope, Dept Pathol, Natl Med Ctr

External person

Bjorn-Tore Gjertsen

  • University of Bergen, Bergen, Norway
  • Haukeland Hosp, University of Bergen, Haukeland University Hospital, Childrens Clin
  • University of Bergen

External person

Ragnar Lonnerbro

  • Skane Univ Hosp Lund, Lund University, Skane University Hospital, Childrens Hosp Lund, Dept Paediat Surg
  • Lund University

External person

Mikolaj Slabicki

  • German Canc Res Ctr, German Cancer Research Center, Helmholtz Association, Unit Mol Epidemiol C080, DKFZ

External person

Davide Rossi

  • Oncol Inst Southern Switzerland, Div Hematol

External person

Riikka Keski-Filppula

  • University of Oulu

External person

Yiyi Yan

  • York Hosp, Dept Med

External person

S. N. Byrne

  • Univ Sydney, University of Sydney, Bosch Inst, Sydney Med Sch, Discipline Pathol,Sch Med Sci
  • Univ Sydney, University of Sydney, Sch Med Sci, Discipline Appl Med Sci
  • University of Sydney ja Sydney Children's Hospital
  • International Consortium for Health Outcomes measurements (ICHOM)

External person

R. K. Khajuria

  • University of Helsinki, Helsinki

External person

Andreas Mock

  • EBI, European Molecular Biology Laboratory (EMBL), EMBL

External person

M. Lanasa

  • Duke Univ, Duke University, Med Ctr, Ctr Genom & Computat Biol

External person

Kwang Seok Lee

  • German Canc Res Ctr, German Cancer Research Center, Helmholtz Association, Unit Mol Epidemiol C080, DKFZ

External person

Andrea Binatti

  • Univ Padua, University of Padua, Dept Mol Med

External person

Kristin Ladell

  • Cardiff Univ, Cardiff University, Sch Med, Inst Infect & Immun

External person

Catherine S. Lewis

  • Univ Bristol, University of Bristol, Fac Hlth Sci

External person

Anna Jauch

  • Univ Heidelberg Hosp, Ruprecht Karl University Heidelberg, Inst Human Genet, Dept Human Genet

External person

Fernando Terron

  • IMMED SL, Immunol & Med Prod

External person

Georg Hopfinger

  • Salzburger Univ Klinikum
  • Medical University of Vienna

External person

J E Smith

  • European Association of Urology

External person

Javier Loscertales

  • Hosp Univ La Princesa, Dept Hematol, Inst Invest Sanitaria Princesa IIS IP

External person

Hanna Juntti

  • Oulu University Hospital
  • University of Oulu

External person

Manuel Fresno

  • CSIC UAM, Consejo Superior de Investigaciones Cientificas (CSIC), CSIC - Centro de Biologia Molecular Severo Ochoa (CBM), Ctr Biol Mol Severo Ochoa, Dept Cell Biol & Immunol

External person

Sophie Rabe

  • German Canc Res Ctr, German Cancer Research Center, Helmholtz Association, Unit Mol Epidemiol C080, DKFZ

External person

Leopold Sellner

  • German Canc Res Ctr, German Cancer Research Center, Helmholtz Association, Unit Mol Epidemiol C080, DKFZ

External person

G Crispatzu

  • Univ Cologne UoC, Ctr Mol Med, CMMC
  • Univ Cologne UoC, University of Cologne, Ctr Mol Med Cologne

External person

S. Zha

  • Columbia Univ, Columbia University, Inst Canc Genet, Dept Pathol & Cell Biol,Med Ctr, Div Pediat Oncol,Dept Pediat,Herbert Irving Compr

External person

Shihui Wang

  • German Canc Res Ctr, German Cancer Research Center, Helmholtz Association, Unit Mol Epidemiol C080, DKFZ

External person

Terhi Tapiainen

  • University of Oulu
  • Oulu University Hospital
  • Univ Oulu, University of Oulu, Bioctr Oulu, Microarray Core Facil
  • PEDEGO Research Unit, MRC Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland
  • Baylor Coll Med, Baylor College of Medicine, Baylor Liver Hlth
  • Oulu University Hospital and Medical Research Center Oulu
  • University Hospital
  • University of Oulu

External person

Thomas Olson

  • Univ Virginia, University of Virginia, Ctr Canc

External person

Tanja Skytta

  • Tampere University Hospital (TAYS)
  • Tampere Univ Hosp, Tampere University, Tampere University Hospital, Div Nephrol
  • Tampere University Hospital

External person

Timo Siitonen

  • University of Oulu, Oulu
  • University of Oulu
  • Univ Oulu, University of Oulu, Dept Psychiat, Lapland Hosp Dist, Dept Clin Med

External person

Linus Wahnschaffe

  • Department I of Internal Medicine, Center for Integrated Oncology (CIO), Aachen-Bonn-Cologne-Duesseldorf, University of Cologne (UoC), 50937 Cologne, Germany
  • Univ Cologne, University of Cologne, Ctr Mol Med, CMMC
  • Univ Cologne UoC, University of Cologne, Ctr Mol Med Cologne
  • Univ Cologne, University of Cologne, Cologne Bioctr, Inst Genet

External person

Steffen Koschmieder

  • RWTH Aachen University, Aachen, Germany
  • Rhein Westfal TH Aachen, RWTH Aachen University, Fac Med, Dept Hematol Oncol Hemostaseol & Stem Cell Transp

External person

Kelly L. Miners

  • Cardiff Univ, Cardiff University, Sch Med, Inst Infect & Immun

External person

Michelle da Silva Liberio

  • German Canc Res Ctr, German Cancer Research Center, Helmholtz Association, Unit Mol Epidemiol C080, DKFZ

External person

Sari Hamalainen

  • Kuopio University Hospital (KYS)

External person

A Briganti

  • Univ Vita Salute San Raffaele, Vita-Salute San Raffaele University, IRRCS Ist Sci San Raffaele
  • San Raffaele Scientific Institute

External person

Jaroslaw P. Maciejewski

  • Cleveland Clin, Dept Translat Hematol & Oncol Res, Taussig Canc Inst

External person

Mieke Van Hemelrijck

  • Kings Coll London, University of London, Kings College London, Sch Canc & Pharmaceut Sci, TOUR
  • Kings Coll London, University of London, Kings College London, Translat Urol Off
  • University of London
  • Kings College

External person

Bruno Maurer

  • Med Univ Vienna, Medical University of Vienna, Ludwig Boltzmann Institute, Ludwig Boltzmann Inst Canc Res

External person

C. Auffray

  • Association EISBM

External person

Jennifer Huellein

  • German Canc Res Ctr, German Cancer Research Center, Helmholtz Association, Unit Mol Epidemiol C080, DKFZ

External person

Sascha Dietrich

  • Mol Med Partnership Unit MMPU
  • Heidelberg University

External person

Riccardo Campi

  • ESMO Guidelines Comm, European Society for Medical Oncology, ESMO Head Off
  • European Association of Urology

External person

Axel Benner

  • German Canc Res Ctr, German Cancer Research Center (DKFZ), Helmholtz Association, Div Biostat

External person

Amit Kiran

  • Astellas Pharma Europe Ltd

External person

Thomas Olson

  • Penn State Coll Med, Penn State Hershey Canc Inst

External person

T. Jaatinen

  • Finnish Red Cross Blood Serv
  • Finnish Red Cross Blood Serv, Histocompatibil Testing Lab

External person

Raquel Juarez-Sanchez

  • IMMED SL, Immunol & Med Prod

External person

Andres Jerez

  • Cleveland Clin, Cleveland Clinic Foundation, Taussig Canc Inst, Dept Translat Hematol & Oncol Res

External person

Martin Sill

  • German Canc Res Ctr, German Cancer Research Center (DKFZ), Helmholtz Association, Div Biostat
  • Helmholtz Zentrum Geesthacht, Helmholtz Association
  • New York University Langone Medical Center, University of New York, New York, USA

External person

Teemu J. Murtola

  • Univ Tampere, Sch Publ Hlth, Dept Epidemiol
  • Tampere University
  • Tampere University Hospital

External person

Susan Ramadan

  • University of Turku
  • Turku Univ Hosp, University of Turku, Div Med, Dept Nephrol
  • University of Turku and Turku University Hospital

External person

Janine Altmueller

  • University of Cologne
  • Univ Cologne UoC, Inst Human Genet
  • Univ Hosp Cologne, University of Cologne, Ctr Mol Med Cologne, Dept Obstet & Gynaecol, Div Mol Gynecooncol
  • UoC, University of Cologne, Inst Human Genet, Cologne Ctr Genom
  • Univ Cologne, University of Cologne, Med Fac, Ctr Integrated Oncol Cologne Bonn, Dept Translat Genom

External person

Michael Lardas

  • ESMO Guidelines Comm, European Society for Medical Oncology, ESMO Head Off
  • European Association of Urology

External person

Emma Gostick

  • Cardiff Univ, Cardiff University, Sch Med, Inst Infect & Immun

External person

Dennis Jungherz

  • Univ Cologne, University of Cologne, Ctr Mol Med, CMMC
  • Univ Cologne UoC, University of Cologne, Ctr Mol Med Cologne

External person

Richard Rosenquist

  • Karolinska Institutet

External person

Anna Lissina

  • Univ Bristol, University of Bristol, Fac Hlth Sci

External person

Christoph Lutz

  • Univ Heidelberg Hosp, Ruprecht Karl University Heidelberg, Dept Med

External person

Jan Duerig

  • Univ Hosp Essen, University of Duisburg Essen, Dept Hematol
  • Univ Hosp Essen, University of Duisburg Essen, Clin Hematol

External person

A Schrader

  • Univ Cologne UoC, Ctr Mol Med, CMMC
  • UoC, University of Cologne, CMMC
  • Univ Cologne UoC, University of Cologne, Ctr Mol Med Cologne

External person

Thomas Olson

  • Penn State Coll Med, Penn State University, Pennsylvania Commonwealth System of Higher Education (PCSHE), Penn State Hershey Canc Inst

External person

Thomas P. Loughran

  • Univ Virginia, University of Virginia, Ctr Canc
  • Univ Virginia, University of Virginia

External person

Kristiina Tyynela-Korhonen

  • Kuopio University Hospital (KYS)
  • Neuro Center, Kuopio University Hospital, Kuopio, Finland

External person

Sian Llewellyn-Lacey

  • Cardiff Univ, Cardiff University, Sch Med, Inst Infect & Immun

External person

Taru Kuittinen

  • Kuopio University Hospital (KYS)

External person

Anna Kreutzman

  • HY
  • University of Helsinki, Helsinki
  • Hosp Univ La Princesa, Hospital de La Princesa, Dept Immunol, IIS IP

External person

Tamara Mateu-Albero

  • Hosp Univ La Princesa, Hospital de La Princesa, Dept Immunol, IIS IP

External person

Anssi Auvinen

  • University of Tampere
  • Tampere University Hospital (TAYS)
  • Univ Tampere, University of Tampere, Fac Social Sci Logoped
  • Tampere University Hospital, Tampere
  • Tampere University

External person

Marcus Bantscheff

  • Cellzome A GSK Company

External person

Timo Hautala

  • University of Oulu, Oulu
  • University of Oulu

External person

Yaiza Perez-Garcia

  • Hosp Univ La Princesa, Inst Invest Sanitaria Princesa IIS IP, Dept Immunol
  • Hosp Univ La Princesa, Hospital de La Princesa, Dept Immunol, IIS IP

External person

Peter O'Gorman

  • Mater Misericordiae University Hospital

External person

Meri-Sisko Vuoristo

  • Pirkanmaa Canc Soc
  • Univ Tampere, Tampere University, Tampere University Hospital, Tampere Univ Hosp, Fac Med & Hlth Technol, Allergy Ctr
  • Tampere Univ Hosp, Tampere University, Tampere University Hospital, Div Nephrol

External person

E. Vasyutina

  • Univ Cologne UoC, Ctr Mol Med, CMMC

External person

Ana Urzainqui

  • Hosp Univ La Princesa, Hospital de La Princesa, Dept Immunol, IIS IP

External person

Stephan Stilgenbauer

  • Univ Hosp, University of Ulm, Dept Med, Dept Internal Med
  • Univ Ulm, University of Ulm, Dept Internal Med, Div Cardiol
  • Univ Ulm, University of Ulm, Med Ctr
  • Univ Ulm, University of Ulm, Div Neurophysiol
  • Univ Ulm, University of Ulm, Dept Neurol

External person

T. Haferlach

  • MLL Munich Leukemia Lab

External person

Christof von Kalle

  • Heidelberg Ctr Personalized Oncol, German Cancer Research Center (DKFZ), Helmholtz Association, DKFZ, DKFZ HIPO
  • German Canc Res Ctr DKFZ Heidelberg, Helmholtz Association, German Cancer Research Center (DKFZ), Div Canc Epidemiol

External person

Yok-Lam Kwong

  • University of Hong Kong

External person

Peter Mayer

  • Univ Munich, Dept Chem
  • Univ Cologne UoC, Ctr Mol Med, CMMC
  • UoC, University of Cologne, CMMC
  • Univ Cologne UoC, University of Cologne, Ctr Mol Med Cologne

External person

Michael J. Clemente

  • Cleveland Clin, Dept Translat Hematol & Oncol Res, Taussig Canc Inst

External person

Alun Parsons

  • Univ Helsinki, Inst Mol Med Finland

External person

Alex Asiimwe

  • Bayer Pharma AG, Bayer AG, Bayer Healthcare Pharmaceuticals, Sect Bioinformat
  • Bayers AG

External person

Thomas P. Loughran

  • Penn State Coll Med, Penn State Hershey Canc Inst

External person

Andrew Herman

  • Univ Bristol, University of Bristol, Fac Hlth Sci

External person

Nicolas Mottet

  • ESMO Guidelines Comm, European Society for Medical Oncology, ESMO Head Off
  • European Association of Urology

External person

Dan Zhang

  • Penn State Coll Med, Penn State University, Pennsylvania Commonwealth System of Higher Education (PCSHE), Penn State Hershey Canc Inst

External person

Sebastiaan Remmers

  • Erasmus University Medical Center Rotterdam
  • Erasmus MC Cancer Institute
  • Erasmus Univ, Erasmus University Rotterdam, Erasmus University Rotterdam, Inst Hlth Policy & Management iBMG
  • Erasmus University Medical Center

External person

Thomas P. Loughran

  • Penn State Hershey Coll Med, Penn State University, Pennsylvania Commonwealth System of Higher Education (PCSHE), Penn State Hershey Canc Inst

External person

Linda Wooldridge

  • Univ Bristol, University of Bristol, Fac Hlth Sci

External person

Bian Wu

  • German Canc Res Ctr, German Cancer Research Center, Helmholtz Association, Unit Mol Epidemiol C080, DKFZ

External person

Christopher A. Eide

  • Howard Hughes Medical Institute
  • MIT, Howard Hughes Medical Institute, Massachusetts Institute of Technology (MIT), Howard Hughes Med Inst

External person

L. Fialho

  • International Consortium for Health Outcomes measurements (ICHOM)

External person

Andrzej K. Oles

  • EBI, European Molecular Biology Laboratory (EMBL), EMBL

External person

Alessandro Coppe

  • Univ Padua, University of Padua, Dept Biol

External person

T. Braun

  • Study Grp Perinatal Programming, Charite Medical University of Berlin, Humboldt University of Berlin, Free University of Berlin, Div Expt Obstet
  • Univ Cologne UoC, Ctr Mol Med, CMMC
  • UoC, University of Cologne, CMMC
  • Univ Cologne UoC, University of Cologne, Ctr Mol Med Cologne

External person

Enrico Alleva

  • Section of Behavioural Neurosciences, Department of Cell Biology and Neurosciences, Istituto Superiore di Sanità, 00161 Rome
  • San Raffaele Scientific Institute

External person

H. Christian Reinhardt

  • UoC, Excellence Cluster Cellular Stress Response & Agi
  • Univ Duisburg Essen, University of Duisburg Essen

External person

Carlo Cuesta-Mateos

  • IMMED SL, Immunol & Med Prod

External person

Britta Velten

  • EBI, European Molecular Biology Laboratory (EMBL), EMBL

External person

N. Pflug

  • Univ Cologne UoC, Ctr Integrated Oncol CIO Koln Bonn, Dept Internal Med
  • Univ Cologne UoC, University of Cologne, Dept Internal Med 1, Ctr Integrated Oncol Aachen Bonn Cologne Duesseld

External person

K. Warner

  • Goethe Univ, Goethe University Frankfurt, Senckenberg Inst Pathol

External person

Andrey Zavialov

  • University of Turku
  • Guangzhou Women & Childrens Med Ctr, Guangzhou Inst Pediat

External person

Katja Zirlik

  • Tumorzentrum ZeTuP Chur

External person

Christopher C. Oakes

  • German Canc Res Ctr, German Cancer Research Center (DKFZ), Helmholtz Association, Div Epigen & Canc Risk Factors

External person

Alexander Jethwa

  • German Canc Res Ctr, German Cancer Research Center, Helmholtz Association, Unit Mol Epidemiol C080, DKFZ

External person

Thomas P. Loughran

  • Penn State Coll Med, Penn State University, Pennsylvania Commonwealth System of Higher Education (PCSHE), Penn State Hershey Canc Inst

External person

Tuija Lundan

  • University of Turku
  • Turku University Hospital

External person

A. Binatti

  • Univ Padua, University of Padua

External person

Till Braun

  • Department I of Internal Medicine, Center for Integrated Oncology (CIO), University of Cologne (UoC), Germany
  • Univ Cologne, University of Cologne, Dept Internal Med 1, CMMC, CIO ABCD,CECAD
  • Univ Cologne, University of Cologne, Cologne Bioctr, Inst Genet

External person

Brian J. Druker

  • Howard Hughes Medical Institute
  • MIT, Howard Hughes Medical Institute, Massachusetts Institute of Technology (MIT), Howard Hughes Med Inst
  • Oregon Hlth & Sci Univ, Oregon Health & Science University, Knight Canc Inst, Div Hematol & Med Oncol

External person

Patricia Fuentes

  • CSIC UAM, Consejo Superior de Investigaciones Cientificas (CSIC), CSIC - Centro de Biologia Molecular Severo Ochoa (CBM), Immune Syst Dev & Funct Unit, Ctr Biol Mol Severo Ochoa

External person

Andriy Mokhir

  • Friedrich Alexander Univ Erlangen Nurnberg, University of Erlangen Nuremberg, Dept Chem & Pharm Organ Chem 2

External person

Thorsten Zenz

  • Univ Zurich, University of Zurich, Dept Hematol
  • Natl Ctr Tumor Dis NCT, Helmholtz Association, German Cancer Research Center (DKFZ), Ruprecht Karls University Heidelberg, Div Prevent Oncol

External person

K. S. J. Elenitoba-Johnson

  • Univ Penn, University of Pennsylvania, Dept Pathol & Lab Med, Perelman Sch Med, Ctr Neurodegenerat Dis Res

External person

Sean Power

  • Imperial College London

External person

Billy Franks

  • Julius Clinical

External person

M. Hallek

  • UoC, Excellence Cluster Cellular Stress Response & Agi
  • Univ Cologne UoC, University of Cologne, Ctr Mol Med Cologne

External person

Marc Zapatka

  • German Canc Res Ctr, Helmholtz Association, German Cancer Research Center (DKFZ), Div Mol Genet

External person

Karl Pang

  • ESMO Guidelines Comm, European Society for Medical Oncology, ESMO Head Off
  • European Association of Urology

External person

Kalle E. Mattila

  • Turku Univ Hosp, University of Turku, Div Med, Dept Nephrol
  • Univ Turku, University of Turku, Clin Neurosci, Dept Neurosurg, Turku Brain Injury Ctr,Turku Univ Hosp
  • University of Turku and Turku University Hospital

External person

Marina Lukas

  • German Canc Res Ctr, German Cancer Research Center, Helmholtz Association, Unit Mol Epidemiol C080, DKFZ

External person

Xiyang Liu

  • German Canc Res Ctr, German Cancer Research Center, Helmholtz Association, Unit Mol Epidemiol C080, DKFZ

External person

Junyan Lu

  • EBI, European Molecular Biology Laboratory (EMBL), EMBL

External person

P. Frommolt

  • UoC, CECAD, Bioinformat Core Facil

External person

Manfred Hensel

  • Mannheim Oncol Practice

External person

A. Coppe

  • Univ Padua, University of Padua

External person

Michael Hershfield

  • Duke Univ, Med Ctr, Dept Med & Biochem
  • Duke Univ, Duke University, Sch Med, Dept Med & Biochem
  • Duke Univ, Duke University, Dept Med & Biochem, Med Ctr

External person

S. Lejeune

  • EORTC Headquarters

External person

M-H Stern

  • PSL Res Univ, Institut Curie, PSL Research University Paris (ComUE), UNICANCER, Institut National de la Sante et de la Recherche Medicale (Inserm), Inst Curie, INSERM U830
  • PSL Res Univ, Institut National de la Sante et de la Recherche Medicale (Inserm), University of Paris Descartes, UNICANCER, Institut Curie, PSL Research University Paris (ComUE), Universite Sorbonne Paris Cite-USPC (ComUE), Inst Curie, INSERM, U830,DNA Repair & Uveal Melanoma DRUM,Equipe Lsab

External person

Tatjana Walther

  • German Canc Res Ctr, German Cancer Research Center, Helmholtz Association, Unit Mol Epidemiol C080, DKFZ

External person

Edgar Faber

  • Univ Hosp Olomouc, Dept Hematooncol
  • Palacky Univ, Palacky University Olomouc, University Hospital Olomouc, Univ Hosp, Dept Hematol Oncol
  • Palacky Univ, Palacky University Olomouc, University Hospital Olomouc, University Hospital Plzen, Fac Hosp Olomouc, Fac Med & Dent, Dept Hematooncol

External person

Giorgio Gandaglia

  • Univ Vita Salute San Raffaele, Vita-Salute San Raffaele University, Div Neurosci, San Raffaele Sci Inst
  • European Association of Urology
  • San Raffaele Scientific Institute

External person

T Visakorpi

  • Tampere University

External person

Derya Tilki

  • Hamburg University - Universität Hamburg
  • University Clinic Hamburg-Eppendorf

External person

Pia Vihinen

  • Turku University Hospital
  • Turku Univ Hosp, University of Turku, Div Med, Dept Nephrol
  • Univ Turku, University of Turku, FICAN West
  • University of Turku and Turku University Hospital

External person

Mathew Clement

  • Cardiff Univ, Cardiff University, Sch Med, Inst Infect & Immun

External person

C. D. Herling

  • UoC, Excellence Cluster Cellular Stress Response & Agi

External person

Matteo Ratti

  • Univ Piemonte Orientale Amedeo Avogadro, University of Eastern Piedmont Amedeo Avogadro, Dipartimento Sci & Tecnol Avanzate
  • San Raffaele Scientific Institute

External person

Sonja Ghidelli-Disse

  • Cellzome A GSK Company

External person

Rossella Nicoletti

  • European Association of Urology

External person

Joe Lewis

  • EMBL, European Molecular Biology Laboratory (EMBL), Chem Biol Core Facil

External person

Blanca Andrea Sanchez-Lopez

  • Hosp Univ La Princesa, Hospital de La Princesa, Dept Immunol, IIS IP

External person

R. Bangma

  • Erasmus University Medical Center

External person

David E. Hamm

  • Adaptive Biotechnol Corp

External person

Emma Young

  • Karolinska Institutet

External person

A. John Barrett

  • NHLBI, National Institutes of Health (NIH) - USA, NIH National Heart Lung & Blood Institute (NHLBI), Stem Cell Allogene Transplantat Sect, Hematol Branch, NIH

External person

Jorrit M. Enserink

  • Oslo University
  • Oslo University Hospital and University of Oslo
  • University of Oslo
  • Oslo University

External person

F. Beier

  • Uniklin RWTH Aachen, RWTH Aachen University, Dept Hematol Oncol Hemostaseol & Stem Cell Transp, Fac Med
  • Rhein Westfal TH Aachen, RWTH Aachen University, Med Sch, Dept Hematol Oncol & Stem Cell Transplantat

External person

Kostantino Stamatakis

  • CSIC UAM, Consejo Superior de Investigaciones Cientificas (CSIC), CSIC - Centro de Biologia Molecular Severo Ochoa (CBM), Ctr Biol Mol Severo Ochoa, Dept Cell Biol & Immunol

External person

L Sellner

  • Heidelberg Univ, Ruprecht Karls University Heidelberg, Heidelberg Inst Global Hlth

External person

Syed Arshi Uz Zaman

  • Univ Helsinki, University of Helsinki, Inst Mol Med FIMM

External person

Pirjo Koistinen

  • Oulu University Hospital

External person

S. Oberbeck

  • UoC, University of Cologne, CMMC
  • Univ Cologne UoC, University of Cologne, Ctr Mol Med Cologne

External person

Maria Luisa Toribio

  • CSIC UAM, Consejo Superior de Investigaciones Cientificas (CSIC), CSIC - Centro de Biologia Molecular Severo Ochoa (CBM), Immune Syst Dev & Funct Unit, Ctr Biol Mol Severo Ochoa

External person

Thomas Olson

  • Penn State Hershey Coll Med, Penn State University, Pennsylvania Commonwealth System of Higher Education (PCSHE), Penn State Hershey Canc Inst

External person

Maria J. Ribal

  • the University of Barcelona
  • ESMO Guidelines Comm, European Society for Medical Oncology, ESMO Head Off
  • European Association of Urology

External person

Dean A. Lee

  • Nationwide Childrens Hosp, Ohio State University, Div Hematol Oncol & BMT
  • Nationwide Children's Hospital

External person

Yi Lin

  • Fred Hutchinson Canc Res Ctr, Fred Hutchinson Cancer Center

External person

Cecilia Munoz-Calleja

  • Hosp Univ La Princesa, Inst Invest Sanitaria Princesa IIS IP, Dept Immunol
  • Univ Autonoma Madrid, Autonomous University of Madrid

External person

Anders Bjartell

  • University of Lund
  • Lund University

External person

A. Riabinska

  • UoC, Excellence Cluster Cellular Stress Response & Agi

External person

Vladislav Kim

  • EBI, European Molecular Biology Laboratory (EMBL), EMBL

External person

Sina Oppermann

  • German Canc Res Ctr, German Cancer Research Center, Helmholtz Association, Unit Mol Epidemiol C080, DKFZ
  • Helmholtz Zentrum Geesthacht, Helmholtz Association

External person

S. Bortoluzzi

  • University of Helsinki, Helsinki
  • Univ Padua, University of Padua

External person

R Shepherd

  • European Association of Urology

External person

M. Clemente

  • Cleveland Clin Fdn, Cleveland Clinic Foundation

External person

Peter-Paul Willemse

  • ESMO Guidelines Comm, European Society for Medical Oncology, ESMO Head Off
  • European Association of Urology

External person

Wolfgang Huber

  • Mol Med Partnership Unit MMPU

External person

Dan Zhang

  • Shanghai Jiao Tong Univ, Shanghai Jiao Tong University, Hongqiao Inst Med, Tongren Hosp, Fac Basic Med,Sch Med
  • Sichuan Univ, Sichuan University, West China Univ Hosp 2, Dept Pediat Infect Dis, Key Lab Birth Defects & Related Dis Women & Child
  • Ruprecht Karls University, Heidelberg

External person

Christoph Plass

  • German Consortium Translat Canc Res DKTK, Helmholtz Association, German Cancer Research Center (DKFZ)
  • German Canc Res Ctr, German Cancer Research Center (DKFZ), Helmholtz Association, Div Epigen & Canc Risk Factors

External person

S. Newrzela

  • Goethe Univ, Goethe University Frankfurt, Senckenberg Inst Pathol

External person

S. Pützer

  • Univ Cologne UoC, Ctr Mol Med, CMMC

External person

P. Palaiologou B. De Meulder

  • European Cancer Patient Coalition
  • Association EISBM

External person

Lesley Ann Sutton

  • Karolinska Institutet

External person

Kathryn Guinta

  • Cleveland Clin, Dept Translat Hematol & Oncol Res, Taussig Canc Inst

External person

Arantzazu Alfranca

  • Hosp Univ La Princesa, Hospital de La Princesa, Dept Immunol, IIS IP

External person

Alexandra Schrader

  • Department I of Internal Medicine, Center for Integrated Oncology (CIO), University of Cologne (UoC), Germany
  • Univ Cologne, University of Cologne, Ctr Mol Med, CMMC

External person

M Roobol

  • Erasmus University Medical Center

External person

Malgorzata Oles

  • EBI, European Molecular Biology Laboratory (EMBL), EMBL

External person

James E. McLaren

  • Cardiff Univ, Cardiff University, Sch Med, Inst Infect & Immun

External person

Thomas Oellerich

  • German Consortium Translat Canc Res DKTK, Helmholtz Association, German Cancer Research Center (DKFZ)

External person

James N'Dow

  • University of Aberdeen
  • Univ Aberdeen, University of Aberdeen, University of Aberdeen, Acad Ctr Primary Care
  • European Association of Urology

External person

Peter O´Gorman

  • Mater Misericordiae University Hospital

External person